Core Scientific, Inc. (NASDAQ:CORZ) Shares Sold by Blair William & Co. IL

Blair William & Co. IL reduced its position in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 60.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 381,910 shares of the company's stock after selling 588,357 shares during the quarter. Blair William & Co. IL owned approximately 0.14% of Core Scientific worth $5,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its stake in Core Scientific by 25.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company's stock valued at $1,378,000 after acquiring an additional 20,000 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Core Scientific by 44.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,932,462 shares of the company's stock worth $22,919,000 after acquiring an additional 590,946 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company's stock worth $5,192,000 after acquiring an additional 142,068 shares during the period. FNY Investment Advisers LLC raised its stake in shares of Core Scientific by 35.8% during the 4th quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company's stock valued at $2,679,000 after purchasing an additional 50,275 shares during the period. Finally, Josh Arnold Investment Consultant LLC lifted its holdings in Core Scientific by 233.3% during the 3rd quarter. Josh Arnold Investment Consultant LLC now owns 100,000 shares of the company's stock worth $1,186,000 after purchasing an additional 70,000 shares in the last quarter.

Remove Ads

Insiders Place Their Bets

In other Core Scientific news, Director Todd A. Becker sold 134,250 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares of the company's stock, valued at $2,103,635.25. This trade represents a 40.69 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jordan Levy purchased 62,500 shares of Core Scientific stock in a transaction on Thursday, March 6th. The stock was bought at an average price of $8.01 per share, for a total transaction of $500,625.00. Following the completion of the acquisition, the director now owns 306,887 shares in the company, valued at $2,458,164.87. The trade was a 25.57 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 530,041 shares of company stock valued at $7,870,352. 32.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Craig Hallum started coverage on shares of Core Scientific in a report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target on the stock. Canaccord Genuity Group restated a "buy" rating and issued a $17.00 target price on shares of Core Scientific in a research note on Wednesday, March 12th. Cantor Fitzgerald dropped their price target on Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Keefe, Bruyette & Woods began coverage on shares of Core Scientific in a research report on Monday, January 27th. They issued an "outperform" rating and a $22.00 price objective on the stock. Finally, BTIG Research raised their target price on shares of Core Scientific from $19.00 to $20.00 and gave the company a "buy" rating in a research note on Monday, December 16th. Fifteen research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $19.07.

Core Scientific Stock Up 0.4 %

Shares of CORZ traded up $0.03 during trading hours on Friday, hitting $7.18. The company had a trading volume of 24,842,286 shares, compared to its average volume of 12,001,430. The stock's 50 day moving average price is $10.07 and its 200 day moving average price is $12.98. The firm has a market cap of $2.12 billion, a P/E ratio of -1.33 and a beta of 6.80. Core Scientific, Inc. has a 52-week low of $2.61 and a 52-week high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.09. The firm had revenue of $94.93 million during the quarter, compared to analysts' expectations of $97.07 million. On average, research analysts expect that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.